AnaiAnai
AnaiAnai
暂无个人介绍
IP属地:未知
29关注
25粉丝
0主题
0勋章
avatarAnaiAnai
2021-12-28
$FuelCell(FCEL)$Anyone bet earning is better than expected?
avatarAnaiAnai
2021-12-22
$BlackBerry(BB)$Games over?
avatarAnaiAnai
2021-12-21
goodbye
抱歉,原内容已删除
avatarAnaiAnai
2021-12-21
market down what to do?
PLTR Stock Alert: 5 Things to Know About Palantir’s Latest Partnership
avatarAnaiAnai
2021-12-20
$Tiger Brokers(TIGR)$wait at lower price
avatarAnaiAnai
2021-12-19
worth more than many countries.
3 Stocks That Could Be Worth More Than Apple by 2035
avatarAnaiAnai
2021-12-17
Finally, the firm notes that in recent months certain institutions have been disseminating misleading information in order to profiteer from short selling. The firm rejects such malicious short selling activities. We will stay in communication with relevant regulatory authorities and reserve our right to hold those disseminating false information accountable in accordance with the law.
avatarAnaiAnai
2021-12-17
$Tiger Brokers(TIGR)$Time to buy low again. 
avatarAnaiAnai
2021-12-16
bad
EV stocks fell in morning trading,with Lucid sliding over 3%,TuSimple and Xpeng sliding over 2%
avatarAnaiAnai
2021-12-03
$Tiger Brokers(TIGR)$run. no power.
avatarAnaiAnai
2021-12-03
push harder. 
@AnaiAnai:$Tiger Brokers(TIGR)$Tiger too oversold with fear. Time to push up. 
avatarAnaiAnai
2021-12-03
$Tiger Brokers(TIGR)$Tiger too oversold with fear. Time to push up. 
avatarAnaiAnai
2021-12-03
$Tiger Brokers(TIGR)$CEO buying shares can make it up?
avatarAnaiAnai
2021-12-03
$Tiger Brokers(TIGR)$NO DEAD CAT BOUND for Chinese companies?
avatarAnaiAnai
2021-12-03
avatarAnaiAnai
2021-12-03
$Tiger Brokers(TIGR)$200k unit can caused the share price drop to below rm5. Something is unbelievable. Sentiment is so bad now. No one care Tiger whether with future or not. All concern current regulations matters in US and China. lol
avatarAnaiAnai
2021-12-03
vaccine again. 
Novavax stock surged more than 7% in premarket trading
avatarAnaiAnai
2021-12-02
$Tiger Brokers(TIGR)$Tiger Market Cap left 880mil. Tiger founder do nothing to make it back to 1bil?
avatarAnaiAnai
2021-12-02
(Reuters) - Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday.A GSK statement said that lab tests and a study on hamsters have demonstrated the sotrovimab antibody cocktail to work against viruses that were bio-engineered to carry a number of hallmark mutations of the Omicron variant.
avatarAnaiAnai
2021-12-02

去老虎APP查看更多动态